Skip Navigation Change Font Size

Archives - Food and Drug Administration (FDA)

FY 2004

09-20-2004
Review of Food and Drug Administration's Bone Mass Study (A-03-03-00378)

Top

FY 2002

02-13-2002
Review of the Accuracy of the Food and Drug Administration's Official Establishment Inventory (A-15-01-20001)

Top

FY 2001

05-03-2001
Reporting Abuses of Persons with Disabilities (A-01-00-02502)

Top

FY 2000

12-14-1999
Review of the Food and Drug Administration's Handling of Adverse Drug Reaction Reports (A-15-98-50001)

Top

FY 1999

09-01-1999
Review of the Food and Drug Administration's Cost Increases for the Arkansas Regional Laboratory (A-15-98-50002)

Top

FY 1998

07-17-1998
Review of the Annual Reporting Process for Investigational New Drugs Regulated by the Food and Drug Administration's Center for Biologics Evaluation and Research (A-15-96-50001)
07-17-1998
Review of the Food and Drug Administration's Citizen Petition Process (A-15-97-50002)
03-02-1998
Review of the Food and Drug Administration's Internal Controls Over Its Purchase Card Activities (A-15-97-80002)

Top

FY 1997

06-04-1997
Review of the Food and Drug Administration's Inspection Process of Plasma Fractionators (A-03-97-00350)
05-16-1997
Review of the Food and Drug Administration's Handling of Issues Related to Conjugated Estrogens (A-15-96-50002)
05-05-1997
Compliance with the Prompt Payment Act by the Food and Drug Administration (A-15-96-40002)

Top

FY 1996

04-12-1996
Review of the Food and Drug Administration's Processing of 17 Error and Accident Reports Involving Blood (A-03-95-00350)
03-06-1996
Review of the Food and Drug Administration's Processes to Review Medical Device Submissions Under the Pre-Market Approval and Investigational Device Exemption Programs (A-15-95-50001)

Top

FY 1995

09-25-1995
Report on the Audit of the Food and Drug Administration's Revolving Fund for Certification and Other Services for Fiscal Year 1994 (A-17-94-00040)
09-25-1995
Report on the Audit of the Food and Drug Administration's Prescription Drug User Fee Account for Fiscal Year 1994 (A-17-95-00046)
08-02-1995
Review of the Food and Drug Administration's Processing of a New Drug Application for Therafectin (A-15-94-00023)
Reporting Process for Blood Establishments to Notify the Food and Drug Administration of Errors and Accidents Affecting Blood (A-03-93-00352)

Top

FY 1994

09-29-1994
Follow-up Review of Possible Improper Pre-Approval Promotion Activities (A-15-93-00018)

Top

FY 1993

08-27-1993
Financial Audit of the Food and Drug Administration's Revolving Fund for Certification and Other Services (A-15-93-00007)
06-07-1993
Review of the Food and Drug Administration's Headquarters Imprest Fund (A-15-92-00019)
02-26-1993
Follow-Up Review On Internal Control Weaknesses in the Food and Drug Administration's Medical Device 510(k) Review Process (A-03-92-00605)
10-26-1992
Follow-up Review of the Food and Drug Administration's Generic Drug Management Information System (A-15-91-00026)

Top

FY 1992

09-16-1992
Follow-Up Review of the Food and Drug Administration's Generic Drug Approval Process (A-15-91-00025)
08-06-1992
Review of Allegations of Mismanagement at the Food and Drug Administration - Newark District Office (A-02-91-02522)
02-21-1992
Audit of Issues Related to the Food and Drug Administration Review of Bovine Somatotropin (A-15-90-00046)

Top

Return to Archives

I'm Looking For

Let's start by choosing a topic

Exclusions Database Report Fraud
Newsletter Sign Up Envelop Graphic

Stay up to date on the latest OIG news and opinions

Office of Inspector General, U.S. Department of Health and Human Services | 330 Independence Avenue, SW, Washington, DC 20201